Literature DB >> 20967573

Non-functioning pancreatic neuroendocrine tumors--a case report and review of literature.

Murtuza M Rampurwala1, Anupam Kumar, Subramanian Kannan, Pamela Kowalczyk, Surendra Khera.   

Abstract

PURPOSE: Neuroendocrine tumors of pancreas (PNET) are rare pancreatic neoplasms comprising 1-2% of all pancreatic tumors. The overall prognosis and long-term survival for PNET patients is far better than for patients with exocrine pancreatic cancer. PNETs are classified as functional or nonfunctional based on the presence or absence of a specific clinical syndrome associated with hormone oversecretion.
METHODS: We present the case of a 36-year-old female with epigastric and right upper quadrant abdominal pain for 3 months associated with decreased appetite, early satiety and a 20-lb weight loss. On examination, she was cachectic with hepatomegaly.
RESULTS: Laboratory assays showed elevated liver and pancreatic enzymes. On computed tomography (CT) scan of the abdomen and pelvis, there was a low-attenuation mass in the distal pancreatic tail measuring 4.7 × 2.4 cm with multiple liver masses, omental implants, left ovarian mass, and a small amount of ascites. CT-guided liver biopsy on pathology was consistent with a well-differentiated pancreatic neuroendocrine carcinoma with metastasis to the liver. Assays for biomarkers of pancreatic neuroendocrine tumors showed an elevated chromogranin A with normal to non-specific elevations of the rest.
CONCLUSIONS: The patient and her family declined palliative chemoembolization of the liver lesions or palliative chemotherapy and desired home hospice. We describe here the presentation and course of the case as well as a literature review of PNET with particular emphasis on nonfunctioning PNETs.

Entities:  

Mesh:

Year:  2011        PMID: 20967573     DOI: 10.1007/s12029-010-9223-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  28 in total

Review 1.  Neuroendocrine tumors of the gastro-entero-pancreatic system.

Authors:  Sara Massironi; Valentina Sciola; Maddalena Peracchi; Clorinda Ciafardini; Matilde Pia Spampatti; Dario Conte
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 2.  Endocrine tumours of the gastrointestinal tract: Chemotherapy.

Authors:  R Arnold; A Rinke; Ch Schmidt; L Hofbauer
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

3.  Surgical experiences of functioning neuroendocrine neoplasm of the pancreas.

Authors:  Chang Moo Kang; Se Ho Park; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Byong Ro Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

4.  Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors--an antiangiogenic effect?

Authors:  L Y Dirix; P B Vermeulen; H Fierens; B De Schepper; B Corthouts; A T Van Oosterom
Journal:  Anticancer Drugs       Date:  1996-02       Impact factor: 2.248

Review 5.  Neuroendocrine tumors of the pancreas: what's new. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.

Authors:  Anastasios T Dimou; Konstantinos N Syrigos; Muhammad Wasif Saif
Journal:  JOP       Date:  2010-03-05

6.  Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.

Authors:  Erika Hubina; Alexandra M Nanzer; Matthew R Hanson; Enrica Ciccarelli; Marco Losa; Daniela Gaia; Mauro Papotti; Maria Rosaria Terreni; Sahira Khalaf; Suzanne Jordan; Sándor Czirják; Zoltán Hanzély; György M Nagy; Miklós I Góth; Ashley B Grossman; Márta Korbonits
Journal:  Eur J Endocrinol       Date:  2006-08       Impact factor: 6.664

7.  Differences in survival by histologic type of pancreatic cancer.

Authors:  Megan Dann Fesinmeyer; Melissa A Austin; Christopher I Li; Anneclaire J De Roos; Deborah J Bowen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

Review 8.  Neuroendocrine tumors of the pancreas.

Authors:  Florian Ehehalt; Hans D Saeger; C Max Schmidt; Robert Grützmann
Journal:  Oncologist       Date:  2009-05-01

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.

Authors:  Seza A Gulec; Geraldine Mesoloras; William A Dezarn; Patrick McNeillie; Andrew S Kennedy
Journal:  J Transl Med       Date:  2007-03-14       Impact factor: 5.531

View more
  2 in total

1.  Incidental intraoperative discovery of a pancreatic neuroendocrine tumor associated with chronic pancreatitis.

Authors:  Valeriu Surlin; Sandu Ramboiu; Mirela Ghilusi; Iancu Emil Plesea
Journal:  Diagn Pathol       Date:  2012-09-29       Impact factor: 2.644

2.  A Case of Profound Secretory Diarrhea Revealing 2 Primary Neuroendocrine Tumors.

Authors:  Ashley A Thompson; Fathima K Suhail; Kanish Mirchia; Sekou R Rawlins
Journal:  ACG Case Rep J       Date:  2021-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.